COMMUNIQUÉS West-GlobeNewswire

Floré Unveils World’s First Line of Probiotics for Neurodiversity
19/09/2024
New Science-Driven Products Result from Joint Autism Spectrum Disorder Research with Arizona State University SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Floré , a leader in gut health testing and customized [...]
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
19/09/2024
Strategic partnership aims to further develop Cube’s award-winning AI guided platform for Software as a Service (SaaS) for the private sector and large healthcare systems and diagnostic to support clinicians and [...]
International Myeloma Foundation Launches Myelo: The First AI-Powered Responsive Chatbot to Provide Compassionate Myeloma Support for Patients, Care Partners, and Healthcare Professionals
19/09/2024
Partners with ZS Associates and AWS to Develop Groundbreaking First-of-its-kind Gen AI Companion STUDIO CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce [...]
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
19/09/2024
BlueCross BlueShield of North Carolina and Louisiana Medicaid Increase Coverage for Patients with Depression MALVERN, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology [...]
Safety Shot Partners with Launchpad to Tap into the Large and Influential College Student Market
19/09/2024
Launchpad’s Network All Roads Travel (ART) Will Help Raise Brand Awareness for Safety Shot Among Millions of U.S. College Students JUPITER, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Safety Shot , Inc. (Nasdaq: SHOT) (“ [...]
RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer
19/09/2024
Published data shows that chemotherapy delivered via TAMP with prior chemoradiation in Locally Advanced Pancreatic Cancer observed an Overall Survival of 27-months LOS ALTOS, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- [...]
Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
19/09/2024
Topline results expected in fourth quarter of 2024 GLEN ALLEN, Va., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company [...]
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights
19/09/2024
- Fourth-quarter revenue of $0.73 million, up 64% year-over-year – - Full-year revenue of $3.11 million, up 148% year-over-year – - As of June 30, 2024, the Company had $6.30 million in cash - NEW YORK, Sept. 19, 2024 ( [...]
ARCPOINT ADDS FUNCTIONALITY TO ENABLE TELEHEALTH PRACTITIONERS TO ORDER DIAGNOTIC TESTS THROUGH ARCPOINT SYSTEM
18/09/2024
Greenville, South Carolina, Sept. 18, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to report that it has implemented an integration that allows telehealth doctors and [...]
SOGC Statement on CMA Apology to Indigenous Peoples
18/09/2024
VICTORIA, British Columbia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Today, the Society of Obstetricians and Gynaecologists of Canada (SOGC) stands in solidarity with the Canadian Medical Association (CMA) in its apology for [...]
Déclaration de la SOGC sur les excuses de l'AMC pour les torts causés aux peuples autochtones
18/09/2024
VICTORIA, C.-B., 18 sept. 2024 (GLOBE NEWSWIRE) -- Aujourd'hui, la Société des obstétriciens et gynécologues du Canada (SOGC) est solidaire avec l'Association médicale canadienne (AMC) dans ses excuses pour les torts [...]
NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
18/09/2024
RT-NBTXR3 followed by anti-PD-1 demonstrated favorable safety profile, disease control and tumor response in patients both naïve and resistant to anti-PD-1, suggesting that NBTXR3 may prime the immune system before [...]
NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2024
18/09/2024
NBTXR3 activé par radiothérapie suivi d’un anti-PD-1 a montré un profil de sécurité favorable, un contrôle de la maladie et une réponse tumorale chez les patients naïfs et résistants aux anti-PD-1, suggérant que NBTXR3 [...]
SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment
18/09/2024
Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel will take part in the trial TEL AVIV, Israel, Sept. 18, 2024 (GLOBE [...]
Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer
18/09/2024
DUBLIN, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, [...]
Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML
18/09/2024
BOULDER, Colo., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next- [...]
QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform
18/09/2024
QIAGEN adds over 100 new validated QIAcuity digital PCR assays for cancer research, inherited genetic disorders, infectious disease surveillance, and other applications // QIAcuity digital PCR enables accurate and [...]
4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day
18/09/2024
4D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on longest available follow-up data In broad population (Phase 2b), 70% [...]
Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
18/09/2024
COPENHAGEN, Denmark, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has commenced an underwritten public offering of $300,000,000 of American Depositary Shares (“ADSs”), [...]

Pages